Part 7-1 (Psychopharmacology: sedative-hypnotics; antianxiety drugs; antidepressants) Flashcards
Sedative-hypnotic and anti-anxiety drug Primary goals
Relax patient; promote normal sleep
Decrease anxiety without causing excessive sedation
Primary sedative-hypnotics and antianxiety drugs
Benzodiazepines
Sedative-hypnotic benzodiazepines
Estazolam
Quazepam
Temazepam
Triazolam
Antianxiety benzodiazepines
-Cause less sedation Diazepam Chlordiazepoxide Lorazepam Alprazolam
Benzodiazepines effects
Increases effects of GABA by binding to GABA-A receptor
More Cl- enters neuron through GABA channel
“Z” drugs (Sleep)
Zolpidem (Ambien)
Zaleplon (Sonata)
-Not benzos, but still bind to GABA receptors in different spot
-May produce fewer problems when discontinued
Eszopiclone (Sleep)
Lunesta
Not a benzo, but also binds to GABA receptors
Ramelteon (Sleep)
Rozerem
Melatonin receptor agonist
Azapirones (Antianxiety)
Buspirone
Stimulate serotonin receptors in CNS
May decrease anxiety with less sedation and dependence
Slow onset, moderate efficacy
Use of antidepressants as anxiolytics
Patients may have anxiety and depression
Antidepressents can have direct anxiolytic effects
May have fewer side effects than benzos; less addiction
Alternative anti-anxiety drugs
Quetiapine: antipsychotics
Gabapentin: antiseizure
Pregablin: antiseizure
Hydroxyzine: antihistamine
Sedative-hypotonic adverse effects
Residual effects; anterograde amnesia
Complex behaviors (Sleep walking/driving)
Rebound effect
Falls
Tolerance and dependence
Benzos may be linked to Alzheimer disease
Anti-anxiety drug adverse effects
Rebound effect (Increased anxiety when drug stopped)
Falls
Tolerance and dependence
Benzos may be linked to Alzheimer disease
Sleep/anti-anxiety drug rehab concerns
Do not treat the underlying cause
Benefits vs Sedation
Depression
Most common mental illness
Sadness that is incapacitating
Neurochemical basis